Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Sparks

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|May 24, 2008
Overindulgence and metabolic syndrome: is FoxO1 a missing link?Janet D Sparks, Charles E Sparks
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2012
Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemiaJanet D Sparks, Charles E Sparks, Khosrow Adeli
Biochemical and Biophysical Research Communications|November 20, 2012
Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targetingJeffrey M Chamberlain, Colleen O'Dell, Charles E Sparks, et al.
Atherosclerosis|June 1, 2005
Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patientsJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Atherosclerosis|November 9, 2004
Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndromeJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Biochemical and Biophysical Research Communications|May 21, 2013
Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinasesJanet D Sparks, Colleen O'Dell, Jeffrey M Chamberlain, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 27, 2006
PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- miceDoru V Chirieac, Nicholas O Davidson, Charles E Sparks, et al.
European Journal of Clinical Investigation|April 24, 2010
Inflammation reduces HDL protection against primary cardiac riskJames P Corsetti, Ron T Gansevoort, Charles E Sparks, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 24, 2010
Interleukin-6 mediates hepatic hypersecretion of apolipoprotein BJanet D Sparks, Joanne Cianci, Jenny Jokinen, et al.
Atherosclerosis|January 12, 2007
NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patientsJames P Corsetti, Dan Ryan, Arthur J Moss, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|May 24, 2008
Overindulgence and metabolic syndrome: is FoxO1 a missing link?Janet D Sparks, Charles E Sparks
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2012
Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemiaJanet D Sparks, Charles E Sparks, Khosrow Adeli
Biochemical and Biophysical Research Communications|November 20, 2012
Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targetingJeffrey M Chamberlain, Colleen O'Dell, Charles E Sparks, et al.
Atherosclerosis|June 1, 2005
Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patientsJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Atherosclerosis|November 9, 2004
Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndromeJames P Corsetti, Wojciech Zareba, Arthur J Moss, et al.
Biochemical and Biophysical Research Communications|May 21, 2013
Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinasesJanet D Sparks, Colleen O'Dell, Jeffrey M Chamberlain, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 27, 2006
PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- miceDoru V Chirieac, Nicholas O Davidson, Charles E Sparks, et al.
European Journal of Clinical Investigation|April 24, 2010
Inflammation reduces HDL protection against primary cardiac riskJames P Corsetti, Ron T Gansevoort, Charles E Sparks, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 24, 2010
Interleukin-6 mediates hepatic hypersecretion of apolipoprotein BJanet D Sparks, Joanne Cianci, Jenny Jokinen, et al.
Atherosclerosis|January 12, 2007
NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patientsJames P Corsetti, Dan Ryan, Arthur J Moss, et al.
Pageof 4